GlaxoSmithKline currently faces a dozen Zofran lawsuits alleging that the anti-nausea drug caused mothers to give birth to children with birth defects. The lawsuits will likely be consolidated before a judge for the purposes of discovery.
Zofran is an anti-nausea drug approved to treat sickness in cancer patients and post-surgery patients. However, thousands of women have reportedly been given the drug to treat morning sickness, an unapproved use of the medication. Studies have found that taking the drug during pregnancy may increase the risk of birth defects.
GlaxoSmithKline has been in legal trouble surrounding Zofran before. The company paid $3 billion to the U.S. government to settle allegations that it illegally marketed its drugs, including Zofran for unapproved uses. GSK is expected to face increasing birth defects lawsuits as more women come forward with allegations of complications from the drug.